The Hindu Businessline

AI cannot replace clinical trials soon, warns Moderna co-founder Noubar Afeyan

Afeyan cautioned against overhyping AIs ability to cure diseases such as cancer, arguing that scientific progress must be accompanied by greater humility about what researchers understand about human physiology.